(Q38296050)

1 September 2017

title

Tenascin-C aptamers are generated using tumor cells and purified protein (English)

1 reference

1 September 2017

Hicke BJ

1

1 reference

1 September 2017

Marion C

2

1 reference

1 September 2017

Chang YF

3

1 reference

1 September 2017

Gould T

4

1 reference

1 September 2017

Lynott CK

5

1 reference

1 September 2017

Parma D

6

1 reference

1 September 2017

Schmidt PG

7

1 reference

1 September 2017

Warren S

8

1 reference

1 September 2017

language of work or name

English

0 references

publication date

4 October 2001

1 reference

Journal of Biological Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

276

1 reference

1 September 2017

issue

52

1 reference

1 September 2017

page(s)

48644-48654

1 reference

Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implications

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Induction of tenascin in healing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Specific expression of tenascin in human colonic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Tenascin is a stromal marker for epithelial malignancy in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Diversity of oligonucleotide functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Escort aptamers: a delivery service for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

High affinity ligands from in vitro selection: complex targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

The mathematics of SELEX against complex targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Synthesis, deprotection, analysis and purification of RNA and ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Estimation of SELEX pool size by measurement of DNA renaturation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

The neuronal progenitor cells of the forebrain subventricular zone: intrinsic properties in vitro and following transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Inhibitory DNA ligands to platelet-derived growth factor B-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Tenascin expression in human glioma cell lines and normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Combinatorial selection of high affinity RNA ligands to live African trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Anti-L-selectin oligonucleotide ligands recognize CD62L-positive leukocytes: binding affinity and specificity of univalent and bivalent ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

Oligonucleotide inhibitors of human thrombin that bind distinct epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104651200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104651200

1 reference

1 September 2017

1 reference